Global Assets Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.37M Buy
7,951
+4,839
+155% +$4.94M 2.04% 6
2026
Q1
$2.86M Buy
3,112
+293
+10% +$297K 0.82% 24
2025
Q4
$3.03M Sell
2,819
-306
-10% -$293K 0.87% 20
2025
Q3
$2.38M Buy
3,125
+170
+6% +$127K 0.71% 30
2025
Q2
$2.29M Sell
2,955
-159
-5% -$124K 0.9% 24
2025
Q1
$2.37M Buy
3,114
+2,122
+214% +$1.77M 0.45% 52
2024
Q4
$772K Sell
992
-1,293
-57% -$1.07M 0.43% 62
2024
Q3
$2.02M Buy
2,285
+1,708
+296% +$1.54M 1.11% 16
2024
Q2
$522K Buy
577
+27
+5% +$21.6K 0.83% 24
2024
Q1
$418K Buy
+550
New +$391K 0.25% 81
2023
Q4
Sell
-502
Closed -$270K 94
2023
Q3
$270K Buy
+502
New +$259K 0.24% 98

Other funds holding LLY

Global Assets Advisory's LLY Position: Q2 2026 in Review

Global Assets Advisory increased its Eli Lilly (LLY) stake by 155% in Q2 2026, buying an estimated $4.94M and bringing the position to 7,951 shares worth $9.37M. The position accounts for 2.04% of the portfolio, ranked #6.

Global Assets Advisory first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Global Assets Advisory held 7,951 shares of Eli Lilly worth $9.37M as of Q2 2026.
  • Global Assets Advisory bought 4,839 Eli Lilly shares in Q2 2026, an estimated $4.94M.
  • Eli Lilly made up 2.04% of Global Assets Advisory's portfolio in Q2 2026, its #6 holding.
  • Global Assets Advisory first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Global Assets Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.